A systematic review of over 100,000 patients confirms a higher risk of cholelithiasis and GERD with GLP-1RAs, particularly in weight-loss-focused and high-dose formulations.
A systematic review of over 100,000 patients confirms a higher risk of cholelithiasis and GERD with GLP-1RAs, particularly in weight-loss-focused and high-dose formulations.
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
Host Brian Lacy, MD, talks with Dr Rena Yadlapati about determining which patients may need antireflux surgery, types of surgical approaches, and possible complications.
Host Brian Lacy, MD, talks with Dr Rena Yadlapati about determining which patients may need antireflux surgery, types of surgical approaches, and possible complications.
Rena Yadlapati, MD, is director of the Center for Esophageal Diseases and associate professor of Clinical Medicine at the University of California San Diego.
--
TRANSCRIPT:
Dr. Rena Yadlapati:
Hi, I'm Dr. Rena Yadlapati,...
Rena Yadlapati, MD, is director of the Center for Esophageal Diseases and associate professor of Clinical Medicine at the University of California San Diego.
--
TRANSCRIPT:
Dr. Rena Yadlapati:
Hi, I'm Dr. Rena Yadlapati,...
A real-world cohort study found that patients with MASLD and type 2 diabetes who were not using GLP-1 RAs had a signficantly higher rate of hepatic complications compared to patients receiving GLP-1 therapy.
A real-world cohort study found that patients with MASLD and type 2 diabetes who were not using GLP-1 RAs had a signficantly higher rate of hepatic complications compared to patients receiving GLP-1 therapy.
A new study adds to growing evidence that sexual and reproductive health issues are common yet frequently overlooked among younger colorectal cancer survivors.
A new study adds to growing evidence that sexual and reproductive health issues are common yet frequently overlooked among younger colorectal cancer survivors.
Rehospitalization remained common among patients who experienced immune checkpoint inhibitor-associated colitis, indicating that adverse effects often persist beyond ICI exposure.
Rehospitalization remained common among patients who experienced immune checkpoint inhibitor-associated colitis, indicating that adverse effects often persist beyond ICI exposure.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.